The neuropeptide Y (NPY) Y2 receptors are largely dimeric in the kidney, but monomeric in the forebrain

Journal of Receptors and Signal Transduction

Volumn 28, Issue 3, 2008, Pages 245-263

  Parker, S L ^a   Parker, M S ^b   Estes, A M ^a   Wong, Y Y ^a   Sah, R ^c   Sweatman, T ^a   Park, E A ^a   Balasubramaniam, A ^c   Sallee, F R ^c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF MEMPHIS   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

G protein coupled receptor; Gi subunit; Receptor dimer; Receptor monomer

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; DIMER; DIVALENT CATION; G PROTEIN COUPLED RECEPTOR; MONOMER; NEUROPEPTIDE Y2 RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING ASSAY; CONTROLLED STUDY; DRUG INHIBITION; FOREBRAIN; HUMAN; HUMAN CELL; HYPOTHALAMUS; IN VITRO STUDY; KIDNEY CORTEX; NONHUMAN; PYRIFORM CORTEX; SIGNAL TRANSDUCTION;

ANIMALS; CATIONS, DIVALENT; CHO CELLS; CRICETINAE; CRICETULUS; DIMERIZATION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; KIDNEY; MALE; PROSENCEPHALON; PROTEIN BINDING; RABBITS; RATS; RECEPTORS, NEUROPEPTIDE Y; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS;

ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 45849092220     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.1080/10799890802084341     Document Type: Article

References (48)

1. Dinger MC, Bader JE, Kobor AD, Kretzschmar AK, Beck-Sickinger AG. Homodimerization of neuropeptide y receptors investigated by fluorescence resonance energy transfer in living cells. J Biol Chem 2003, 278, 10562-10571.
2. Parker SL, Parker MS, Sallee FR, Balasubramaniam A. Oligomerization of neuropeptide Y (NPY) Y2 receptors in CHO cells depends on functional pertussis toxin-sensitive G-proteins. Regul Pept 2007, 144, 72-81.
3. Baneres JL, Parello J. Structure-based analysis of GPCR function: Evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. J Mol Biol 2003, 329, 815-829.
4. Nobles M, Benians A, Tinker A. Heterotrimeric G proteins precouple with G protein-coupled receptors in living cells. Proc Natl Acad Sci USA 2005, 102, 18706-18711.
5. Ridge KD, Palczewski K. Visual rhodopsin sees the light: Structure and mechanism of G protein signaling. J Biol Chem 2007, 282, 9297-9301.
6. Estes AM, Wong YY, Parker MS, Sah R, Balasubramaniam A, Sallee FR, Parker SL. Neuropeptide Y (NPY) Y2 receptors of rabbit kidney cortex are largely dimeric. Regul Pept 2008, submitted.
7. Armstrong D, Strange PG. Dopamine D2 receptor dimer formation: Evidence from ligand binding. J Biol Chem 2001, 276, 22621-22629.
8. Ciruela F, Casado V, Mallol J, Canela EI, Lluis C, Franco R. Immunological identification of A1 adenosine receptors in brain cortex. J Neurosci Res 1995, 42, 818-828.
9. Xi ZX, Ramamoorthy S, Baker DA, Shen H, Samuvel DJ, Kalivas PW. Modulation of group II metabotropic glutamate receptor signaling by chronic cocaine. J Pharmacol Exp Ther 2002, 303, 608-615.
10. De Jesus ML, Salles J, Meana JJ, Callado LF. Characterization of CB1 cannabinoid receptor immunoreactivity in postmortem human brain homogenates. Neuroscience 2006, 140, 635-643.
11. Horowitz LF, Hirdes W, Suh BC, Hilgemann DW, Mackie K, Hille B. Phospholipase C in living cells: activation, inhibition, Ca2+ requirement, and regulation of M current. J Gen Physiol 2005, 126, 243-262.
12. Wong R, Fabian L, Forer A, Brill JA. Phospholipase C and myosin light chain kinase inhibition define a common step in actin regulation during cytokinesis. BMC Cell Biol 2007, 8, 15.
13. Doods H, Gaida W, Wieland HA, Dollinger H, Schnorrenberg G, Esser F, Engel W, Eberlein W, Rudolf K. BIIE0246: A selective and high affinity neuropeptide Y Y(2) receptor antagonist. Eur J Pharmacol 1999, 384, R3-R5.
14. Parker SL, Parker MS, Crowley WR. Characterization of rabbit kidney and brain pancreatic polypeptide-binding neuropeptide Y receptors: Differences with Y1 and Y2 sites in sensitivity to amiloride derivatives affecting sodium transport. Regul Pept 1999, 82, 91-102.
15. Parker SL. Parker MS, Sah R, Balasubramaniam A, Sallee FR. Pertussis toxin induces parallel loss of neuropeptide Y Y(1) receptor dimers and G(i) alpha subunit function in CHO cells. Eur J Pharmacol 2008, 579, 13-25.
16. Munson PJ, Rodbard D. LIGAND: A versatile computerized approach for characterization of ligand-binding proteins. Anal Biochem 1980, 107, 220-239.
17. 2 subtype of neuropeptide Y receptor of rat brain. Eur. J. Pharmacol. 1996, 318, 193-200.
18. Neer EJ, Wolf LG, Gill DM. The stimulatory guanine-nucleotide regulatory unit of adenylate cyclase from bovine cerebral cortex. ADP-ribosylation and purification. Biochem J 1987, 241, 325-336.
19. Raymond JR, Olsen CL, Gettys TW. Cell-specific physical and functional coupling of human 5-HT1A receptors to inhibitory G protein alpha-subunits and lack of coupling to Gs alpha. Biochemistry 1993, 32, 11064-11073.
20. Brann MR, Collins RM, Spiegel A. Localization of mRNAs encoding the alpha-subunits of signal-transducing G-proteins within rat brain and among peripheral tissues. FEBS Lett 1987, 222, 191-198.
21. Stow JL, Sabolic I, Brown D. Heterogeneous localization of G protein alpha-subunits in rat kidney. Am J Physiol 1991, 261, F831-840.
22. Freitag C, Svendsen AB, Feldthus N, Lossl K, Sheikh SP. Coupling of the human Y2 receptor for neuropeptide Y and peptide YY to guanine nucleotide inhibitory proteins in permeabilized SMS-KAN cells. J Neurochem 1995, 64, 643-650.
23. Sheikh SP, Sheikh MI, Schwartz TW. Y2-type receptors for peptide YY on renal proximal tubular cells in the rabbit. Am J Physiol 1989, 257, F978-984.
24. Price JS, Kenny AJ, Huskisson NS, Brown MJ. Neuropeptide Y (NPY) metabolism by endopeptidase-2 hinders characterization of NPY receptors in rat kidney. Br J Pharmacol 1991, 104, 321-326.
25. Berglund MM, Schober DA, Esterman MA, Gehlert DR. Neuropeptide Y Y4 receptor homodimers dissociate upon agonist stimulation. J Pharmacol Exp Ther 2003, 307, 1120-1126.
26. Granier S, Terrillon S, Pascal R, Demene H, Bouvier M, Guillon G, Mendre C. A cyclic peptide mimicking the third intracellular loop of the V2 vasopressin receptor inhibits signaling through its interaction with receptor dimer and G protein. J Biol Chem 2004, 279, 50904-50914.
27. Breen CM, Mannon PJ, Benjamin BA. Peptide YY inhibits vasopressin-stimulated chloride secretion in inner medullary collecting duct cells. Am J Physiol 1998, 275, F452-457.
28. Breyer MD, Breyer RM. G protein-coupled prostanoid receptors and the kidney. Annu Rev Physiol 2001, 63, 579-605.
29. Gao L, Zhu C, Jackson EK. alpha 2-Adrenoceptors potentiate angiotensin II- and vasopressin-induced renal vasoconstriction in spontaneously hypertensive rats. J Pharmacol Exp Ther 2003, 305, 581-586.
30. Becker M, Umrani D, Lokhandwala MF, Hussain T. Increased renal angiotensin II AT1 receptor function in obese Zucker rat. Clin Exp Hypertens 2003, 25, 35-47.
31. Grouzmann E, Meyer C, Burki E, Brunner H. Neuropeptide Y Y2 receptor signalling mechanisms in the human glioblastoma cell line LN319. Peptides 2001, 22, 379-386.
32. Mochizuki N, Urasawa K, Sanchez A, Insel PA. Developmental regulation of the alpha-subunit of Gq/G11 as determined by quantitative immunoblot analysis. Biochem Biophys Res Commun 1995, 210, 246-252.
33. Labelle M, Boulanger Y, Fournier A, St Pierre S, Savard R. Tissue-specific regulation of fat cell lipolysis by NPY in 6-OHDA-treated rats. Peptides 1997, 18, 801-808.
34. Zhou J, Sims C, Chang CH, Berti-Mattera L, Hopfer U, Douglas J. Proximal tubular epithelial cells possess a novel 42-kilodalton guanine nucleotide-binding regulatory protein. Proc Natl Acad Sci USA 1990, 87, 7532-7535.
35. Armstrong DN, Krenz HK, Modlin IM, Ballantyne GH. Bile salt inhibition of motility in the isolated perfused rabbit terminal ileum. Gut 1993, 34, 483-488.
36. Lang SA, Maron MB. Effect of neuropeptide Y on hemodynamics of the rabbit lung. J Appl Physiol 1998, 84, 618-623.
37. McDonald JK, Han C, Noe BD, Abel PW. High levels of NPY in rabbit cerebrospinal fluid and immunohistochemical analysis of possible sources. Brain Res 1988, 463, 259-267.
38. Bohme I, Morl K, Bamming D, Meyer C, Beck-Sickinger AG. Tracking of human Y receptors in living cells-a fluorescence approach. Peptides 2007, 28, 226-234.
39. Parker SL, Balasubramaniam A. Neuropeptide Y Y2 receptor in health and disease. Br J Pharmacol 2008, doi:10.1038/sj.bjp.0707445.
40. Abbott CR, Small CJ, Kennedy AR, Neary NM, Sajedi A, Ghatei MA, Bloom SR. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake. Brain Res 2005, 1043, 139-144.
41. Pace AJ, Gama L, Breitwieser GE. Dimerization of the calcium-sensing receptor occurs within the extracellular domain and is eliminated by Cys → Ser mutations at Cys101 and Cys236. J Biol Chem 1999, 274, 11629-11634.
42. Rose PM, Fernandes P, Lynch JS, Frazier ST, Fisher SM, Kodukula K, Kienzle B, Seethala R. Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J Biol Chem 1995, 270, 22661-22664.
43. Rieu P, Sugimori T, Griffith DL, Arnaout MA. Solvent-accessible residues on the metal ion-dependent adhesion site face of integrin CR3 mediate its binding to the neutrophil inhibitory factor. J Biol Chem 1996, 271, 15858-15861.
44. Guo W, Shi L, Javitch JA. The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer. J Biol Chem 2003, 278, 4385-4388.
45. Ma AW, Redka DS, Pisterzi LF, Angers S, Wells JW. Recovery of oligomers and cooperativity when monomers of the M2 muscarinic cholinergic receptor are reconstituted into phospholipid vesicles. Biochemistry 2007, 46, 7907-7927.
46. Abel PW, Han C, Noe BD, McDonald JK. Neuropeptide Y: vasoconstrictor effects and possible role in cerebral vasospasm after experimental subarachnoid hemorrhage. Brain Res 1988, 463, 250-258.
47. Ekstrand AJ, Cao R, Bjorndahl M, Nystrom S, Jonsson-Rylander AC, Hassani H, Hallberg B, Nordlander M, Cao Y. Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing. Proc Natl Acad Sci USA 2003, 100, 6033-6038.
48. Lee EW, Grant DS, Movafagh S, Zukowska Z. Impaired angiogenesis in neuropeptide Y (NPY)-Y2 receptor knockout mice. Peptides 2003, 24, 99-106.